Biohaven (BHVN) Current Assets (2021 - 2026)

Biohaven has disclosed Current Assets across 6 years of filings, most recently posting $385.6 million for Q1 2026.

• Current Assets for Q1 2026 came in at $385.6 million, up 0.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $385.6 million (up 0.76% YoY), and the FY2025 annual result was $368.3 million, down 31.6% from the prior year.
• Current Assets came in at $385.6 million for Q1 2026 at Biohaven, up from $368.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $587.0 million in Q4 2022 to a low of $80.6 million in Q3 2022.
• The 5-year median for Current Assets is $434.1 million (2023), against an average of $411.6 million.
• Across the five-year window, Current Assets soared 519.01% in 2022 and slumped 35.95% in 2024, its largest moves.
• Biohaven's Current Assets stood at $587.0 million in 2022, then slipped by 24.62% to $442.4 million in 2023, then advanced by 21.7% to $538.5 million in 2024, then plunged by 31.6% to $368.3 million in 2025, then advanced by 4.7% to $385.6 million in 2026.
• The last three Current Assets figures came in at $385.6 million (Q1 2026), $368.3 million (Q4 2025), and $323.6 million (Q3 2025), per Business Quant data.